Lauryn R Werner1, Jasdeep S Kler2, Monica M Gressett3, Maureen Riegert4, Lindsey K Werner5, Clinton M Heinze6, Joseph G Kern7, Mahyar Abbariki8, Amy K Erbe9, Ravi B Patel10, Raghava N Sriramaneni11, Paul M Harari12, Zachary S Morris13. 1. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: laurynwerner@gmail.com. 2. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: jkler@wisc.edu. 3. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: monica.gressett@gmail.com. 4. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: mbriegert@wisc.edu. 5. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: lkwerner2@wisc.edu. 6. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: cheinze@wisc.edu. 7. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: jgkern@bu.edu. 8. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: abbariki@wisc.edu. 9. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: aerbe@wisc.edu. 10. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: rpatel55@wisc.edu. 11. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: sriramaneni@wisc.edu. 12. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: harari@humonc.wisc.edu. 13. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, United States. Electronic address: zmorris@humonc.wisc.edu.
Abstract
BACKGROUND AND PURPOSE: We recently reported a time-sensitive, cooperative, anti-tumor effect elicited by radiation (RT) and intra-tumoral-immunocytokine injection in vivo. We hypothesized that RT triggers transcriptional-mediated changes in tumor expression of immune susceptibility markers at delayed time points, which may explain these previously observed time-dependent effects. MATERIALS AND METHODS: We examined the time course of changes in expression of immune susceptibility markers following in vitro or in vivo RT in B78 murine melanoma and A375 human melanoma using flow cytometry, immunoblotting, and qPCR. RESULTS: Flow cytometry and immunoblot revealed time-dependent increases in expression of death receptors and T cell co-stimulatory/co-inhibitory ligands following RT in murine and human melanoma. Using high-throughput qPCR, we observed comparable time courses of RT-induced transcriptional upregulation for multiple immune susceptibility markers. We confirmed analogous changes in B78 tumors irradiated in vivo. We observed upregulated expression of DNA damage response markers days prior to changes in immune markers, whereas phosphorylation of the STAT1 transcription factor occurred concurrently with changes following RT. CONCLUSION: This study highlights time-dependent, transcription-mediated changes in tumor immune susceptibility marker expression following RT. These findings may help in the design of strategies to optimize sequencing of RT and immunotherapy in translational and clinical studies.
BACKGROUND AND PURPOSE: We recently reported a time-sensitive, cooperative, anti-tumor effect elicited by radiation (RT) and intra-tumoral-immunocytokine injection in vivo. We hypothesized that RT triggers transcriptional-mediated changes in tumor expression of immune susceptibility markers at delayed time points, which may explain these previously observed time-dependent effects. MATERIALS AND METHODS: We examined the time course of changes in expression of immune susceptibility markers following in vitro or in vivo RT in B78 murinemelanoma and A375humanmelanoma using flow cytometry, immunoblotting, and qPCR. RESULTS: Flow cytometry and immunoblot revealed time-dependent increases in expression of death receptors and T cell co-stimulatory/co-inhibitory ligands following RT in murine and humanmelanoma. Using high-throughput qPCR, we observed comparable time courses of RT-induced transcriptional upregulation for multiple immune susceptibility markers. We confirmed analogous changes in B78 tumors irradiated in vivo. We observed upregulated expression of DNA damage response markers days prior to changes in immune markers, whereas phosphorylation of the STAT1 transcription factor occurred concurrently with changes following RT. CONCLUSION: This study highlights time-dependent, transcription-mediated changes in tumor immune susceptibility marker expression following RT. These findings may help in the design of strategies to optimize sequencing of RT and immunotherapy in translational and clinical studies.
Authors: Chunrong Li; Shyhmin Huang; Eric A Armstrong; David M Francis; Lauryn R Werner; Mark X Sliwkowski; Albert van der Kogel; Paul M Harari Journal: Mol Cancer Ther Date: 2015-07-03 Impact factor: 6.261
Authors: Eva K Sage; Thomas E Schmid; Michael Sedelmayr; Mathias Gehrmann; Hans Geinitz; Marciana N Duma; Stephanie E Combs; Gabriele Multhoff Journal: Radiother Oncol Date: 2015-12-09 Impact factor: 6.280
Authors: Zachary S Morris; Emily I Guy; David M Francis; Monica M Gressett; Lauryn R Werner; Lakeesha L Carmichael; Richard K Yang; Eric A Armstrong; Shyhmin Huang; Fariba Navid; Stephen D Gillies; Alan Korman; Jacquelyn A Hank; Alexander L Rakhmilevich; Paul M Harari; Paul M Sondel Journal: Cancer Res Date: 2016-05-06 Impact factor: 12.701
Authors: Amit A Lugade; Elizabeth W Sorensen; Scott A Gerber; James P Moran; John G Frelinger; Edith M Lord Journal: J Immunol Date: 2008-03-01 Impact factor: 5.422
Authors: Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes Journal: J Exp Med Date: 2006-04-24 Impact factor: 14.307
Authors: Paul A Clark; Raghava N Sriramaneni; Amber M Bates; Won Jong Jin; Justin C Jagodinsky; Reinier Hernandez; Trang Le; Justin J Jeffery; Ian R Marsh; Joseph J Grudzinski; Eduardo Aluicio-Sarduy; Todd E Barnhart; Bryce R Anderson; Ishan Chakravarty; Ian S Arthur; KyungMann Kim; Jonathan W Engle; Bryan P Bednarz; Jamey P Weichert; Zachary S Morris Journal: Radiat Res Date: 2021-06-01 Impact factor: 2.841
Authors: Ravi B Patel; Mingzhou Ye; Peter M Carlson; Abigail Jaquish; Luke Zangl; Ben Ma; Yuyuan Wang; Ian Arthur; Ruosen Xie; Ryan J Brown; Xing Wang; Raghava Sriramaneni; KyungMann Kim; Shaoqin Gong; Zachary S Morris Journal: Adv Mater Date: 2019-09-16 Impact factor: 30.849
Authors: Jaden D Evans; Lindsay K Morris; Henan Zhang; Siyu Cao; Xin Liu; Kristin C Mara; Bradley J Stish; Brian J Davis; Aaron S Mansfield; Roxana S Dronca; Matthew J Iott; Eugene D Kwon; Robert L Foote; Kenneth R Olivier; Haidong Dong; Sean S Park Journal: Int J Radiat Oncol Biol Phys Date: 2018-09-08 Impact factor: 7.038
Authors: Justin C Jagodinsky; Won Jong Jin; Amber M Bates; Reinier Hernandez; Joseph J Grudzinski; Ian R Marsh; Ishan Chakravarty; Ian S Arthur; Luke M Zangl; Ryan J Brown; Erin J Nystuen; Sarah E Emma; Caroline Kerr; Peter M Carlson; Raghava N Sriramaneni; Jonathan W Engle; Eduardo Aluicio-Sarduy; Todd E Barnhart; Trang Le; KyungMann Kim; Bryan P Bednarz; Jamey P Weichert; Ravi B Patel; Zachary S Morris Journal: Theranostics Date: 2021-04-15 Impact factor: 11.600
Authors: David M Routman; Elizabeth Yan; Sujay Vora; Jennifer Peterson; Anita Mahajan; Kaisorn L Chaichana; Nadia Laack; Paul D Brown; Ian F Parney; Terry C Burns; Daniel M Trifiletti Journal: Front Neurol Date: 2018-11-13 Impact factor: 4.003
Authors: Alexander A Pieper; Alexander L Rakhmilevich; Daniel V Spiegelman; Ravi B Patel; Jen Birstler; Won Jong Jin; Peter M Carlson; Deborah H Charych; Jacquelyn A Hank; Amy K Erbe; Willem W Overwijk; Zachary S Morris; Paul M Sondel Journal: J Immunother Cancer Date: 2021-06 Impact factor: 12.469